Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptome profiling of spinal cord vascular fragments of healthy mice that were either treated with imatinib or PBS

ABSTRACT: Transcriptome profiling of spinal cord vascular fragments of healthy mice that were either treated with imatinib or PBS

PROVIDER: PRJNA662115 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Transcriptome profiling of vascular fragments 3h and 24h post MCAO in imatinib and PBS treated mice

Project description:We isolated vascular fragments, representing the BBB, from the ipsilateral hemisphere of imatinib and PBS treated mice 3h and 24h post MCAO induction.

2024-12-01 | GSE137534 | GEO

Transcriptome profiling of vascular fragments at the preclinical, progression and remission phase of EAE in imatinib and PBS treated mice

Project description:Disruption of blood-brain barrier (BBB) integrity is a hallmark of several neurological disorders. Here we show that the BBB is dynamically and differentially affected during the preclinical, progression and remission phase of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). We isolated vascular fragments, representing the BBB, from spinal cords of imatinib and PBS treated mice at the preclinical, progression and remission phase of MOG-EAE as well as from non-immunized, naive mice.

2020-12-25 | GSE150562 | GEO

Transcriptome profiling of spinal cord vascular fragments of healthy mice that were either treated with imatinib or PBS

Project description:The purpose was to determine if imatinib has an effect on the BBB transcriptome in healthy mice.

2020-12-25 | GSE157604 | GEO

Transcriptome profiling of vascular fragments 3h and 24h post MCAO in imatinib and PBS treated mice

Project description:Transcriptome profiling of vascular fragments 3h and 24h post MCAO in imatinib and PBS treated mice

| PRJNA565790 | ENA

Transcriptome profiling of vascular fragments at the preclinical, progression and remission phase of EAE in imatinib and PBS treated mice

Project description:Transcriptome profiling of vascular fragments at the preclinical, progression and remission phase of EAE in imatinib and PBS treated mice

| PRJNA632825 | ENA

Transcriptome analysis of spinal cord microglia and total spinal cord

Project description:Transcriptome analysis of spinal cord microglia and total spinal cord from Lewis rats intratracheally treated with PBS, neomycin or vancomycin.

2021-12-21 | GSE192411 | GEO

RNA-seq of macrophages and microglia from injured spinal cord after IL-13, IL-4 or PBS treatment

Project description:Spinal cord injured mice were treated with IL-13, IL-4 or PBS. Populations of macrophages and microglia were sorted and analyzed separately.

2021-12-03 | GSE158510 | GEO

Imatinib Disrupts Lymphoma Angiogenesis by Targeting Vascular Pericytes

Project description:Pericytes/vascular smooth muscle cells (VSMCs), regulated by platelet-derived growth factor receptor β (PDGFRβ) signaling, play important roles in endothelial survival and vascular stability. Here we report that treatment with imatinib, an inhibitor of PDGFRβ, led to significant tumor growth impairment associated with increased apoptosis in human lymphoma xenografts including Farage, Karpas422 and OCI-Ly7 in SCID mice. Confocal analysis of the tumor tissue showed decreased microvessel density, decreased vascular flow, and increased vascular leak in the imatinib-treated cohorts. Imatinib targeted tumor-associated PDGFRβ+ pericytes in vivo by inducing apoptosis and disruption of the PDGFRβ+ perivascular network, and PDGFRβ+ VSMC in vitro by inhibition of proliferation. FACS analysis of mononuclear cell suspension of tumor tissues revealed decreased mature pericytes and endothelial cells, as well as their progenitors with imatinib treatment. Compared to imatinib, treatment with anti-PDGFRβ monoclonal antibody partially inhibited the growth of Farage lymphomas. Lastly, microarray analysis of differentially expressed genes in PDGFRβ+ VSMC following imatinib treatment showed significant down-regulation of genes implicated in proliferation, survival and angiogenesis, including those within PI3K/AKT and MAPK/ERK1/2 pathways downstream of PDGFRβ signaling. Taken together, targeting PDGFRβ+ pericytes in lymphoma presents a novel and complementary target to endothelial cells for efficacious antiangiogenic therapy.

2013-04-22 | GSE30752 | GEO

Transcriptome profiling of vascular fragments in mice intracerebroventricular (ICV) injected with platelet derived dermal growth factor CC (PDGF-CC)

Project description:We isolated vascular fragments, representing the BBB, from left brain hemisphere of PDGF-CC and PBS ICV injected mice

2022-06-01 | GSE176245 | GEO

Imatinib Disrupts Lymphoma Angiogenesis by Targeting Vascular Pericytes

2013-04-22 | E-GEOD-30752 | biostudies-arrayexpress